Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.41 |
| ▸ | AGXT | P21549 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | ERN1 | O75460 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 5/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.36 |
| ▸ | MIF | P14174 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2263098 | 0.84 | IDO1 (0.37) | IDO1AGXTMAOB | |
| SCHEMBL487468 | 0.84 | IDO1 (0.48) | IDO1AGXTFFAR1ERN1MAOB | |
| SCHEMBL896415 | 0.79 | IDO1 (0.33) | IDO1AGXTMAOB | |
| SCHEMBL28044711 | 0.79 | ENPP2 (0.41) | — | |
| SCHEMBL2262212 | 0.79 | TSHR (0.38) | IDO1AGXT | |
| SCHEMBL1004736 | 0.78 | IDO1 (0.41) | IDO1AGXTFFAR1ERN1MAOB | |
| SCHEMBL15260899 | 0.78 | CYP3A4 (0.37) | IDO1AGXT | |
| SCHEMBL1338691 | 0.77 | AGXT (0.55) | IDO1AGXTERN1L3MBTL1BRD4 | |
| SCHEMBL29644212 | 0.77 | AGXT (0.55) | IDO1AGXTERN1L3MBTL1BRD4 | |
| SCHEMBL3056959 | 0.76 | CHRM2 (0.39) | IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11992012-B2 | Diaminotriazine compounds | BASF SE (DE) | 2024-05-28 | — | — | US | disclosed |
| US-20210186021-A1 | DIAMINOTRIAZINE COMPOUNDS | BASF SE (DE) | 2021-06-24 | — | — | US | disclosed |
| EP-2647644-B1 | 2'-O-MODIFIED RNA | WAVE LIFE SCIENCES JAPAN INC (JP) | 2020-09-09 | — | — | EP | disclosed |
| WO-2019025153-A1 | USE OF SUBSTITUTED N-SULFONYL-N'-ARYL DIAMINOALKANES AND N-SULFONYL-N'-HETEROARYL DIAMINOALKANES OR SALTS THEREOF FOR INCREASING THE STRESS TOLERANCE IN PLANTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-02-07 | — | — | WO | disclosed |
| US-10065926-B2 | Use of substituted dihydrooxindolylsulfonamides, or the salts thereof, for increasing the stress tolerance of plants | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-09-04 | — | — | US | disclosed |
| US-20180199575-A1 | SUBSTITUTED OXOTETRAHYDROQUINOLINYLPHOSPHINIC ACID AND PHOSPHINIC ACID AMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-07-19 | — | — | US | disclosed |
| EP-3322296-A1 | SUBSTITUTED OXO-TETRAHYDROQUINOLINYL-PHOSPHINIC ACID AND PHOSPHINIC ACID AMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS | Bayer CropScience Aktiengesellschaft (DE) | 2018-05-23 | — | — | EP | disclosed |
| US-20180020662-A1 | Substituted 1-cycloalkyl-2-oxotetrahydroquinolin-6-ylsulfonamides or salts thereof and use thereof to increase stress tolerance in plants | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-01-25 | — | — | US | disclosed |
| EP-3256448-A1 | SUBSTITUTED 1-CYCLOALKYL-2-OXOTETRAHYDROQUINOLIN-6-YL-SULFONAMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS | Bayer CropScience Aktiengesellschaft (DE) | 2017-12-20 | — | — | EP | disclosed |
| EP-3051946-B1 | USE OF SUBSTITUTED DIHYDROOXINDOLYLSULFONAMIDES OR THEIR SALTS FOR INCREASING STRESS TOLERANCE IN PLANTS | BAYER CROPSCIENCE AG (DE) | 2017-11-29 | — | — | EP | disclosed |
| CN-100582087-C | 2-amino-bicyclo [3.1.0] hexane-2, 6-dicarboxylic acid ester derivatives | TAISHO PHARMACEUTICAL CO LTD | 2010-01-20 | — | — | CN | disclosed |
| US-20090306408-A1 | 2-Amino-Bicyclo (3.1.0) Hexane-2,6-Dicarboxylic Ester Derivative | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2009-12-10 | — | — | US | disclosed |
| EP-2123630-A1 | 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative | Taisho Pharmaceutical Co. Ltd. (JP) | 2009-11-25 | — | — | EP | disclosed |
| US-20080090914-A1 | Staining Composition For Staining An Ophthalmic Membrane | NATIONAL UNIVERSITY CORPORATION KYUSHU UNIVERSITY (JP) | 2008-04-17 | — | — | US | disclosed |
| EP-1819366-A4 | A STAINING COMPOSITION FOR STAINING AN OPHTHALMIC MEMBRANE | UNIV KYUSHU NAT UNIV CORP (JP) | 2008-04-16 | — | — | EP | disclosed |
| EP-1819366-A1 | A STAINING COMPOSITION FOR STAINING AN OPHTHALMIC MEMBRANE | Kyushu University, National University Corporation (JP) | 2007-08-22 | — | — | EP | disclosed |
| US-20070021394-A1 | 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2007-01-25 | — | — | US | disclosed |
| CN-1812960-A | 2-amino-bicyclo [3.1.0] hexane-2, 6-dicarboxylic acid ester derivatives | TAISHO PHARMACEUTICAL CO LTD (JP) | 2006-08-02 | — | — | CN | disclosed |
| WO-2006062233-A1 | A STAINING COMPOSITION FOR STAINING AN OPHTHALMIC MEMBRANE | NATIONAL UNIVERSITY CORPORATION KYUSHU UNIVERSITY (JP) | 2006-06-15 | — | — | WO | disclosed |
| EP-1637517-A1 | 2-AMINOBICYCLO 3.1.0 HEXANE-2,6-DICARBOXYLIC ESTER DERIVATIVE | Taisho Pharmaceutical Co. Ltd. (JP) | 2006-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10065926-B2 | Use of substituted dihydrooxindolylsulfonamides, or the salts thereof, for increasing the stress tolerance of plants | SQOR, DHPS, QDPR | IDO1 610/4885AGXT 123/4885FFAR1 3298/4885 |
| US-20080090914-A1 | Staining Composition For Staining An Ophthalmic Membrane | BSG, CD68, MB | IDO1 4058/4885AGXT 4677/4885FFAR1 2084/4885 |
| US-20210186021-A1 | DIAMINOTRIAZINE COMPOUNDS | DDT, DAZAP1, DDC | IDO1 113/4885AGXT 199/4885FFAR1 4593/4885 |
| US-11992012-B2 | Diaminotriazine compounds | DDT, DAZAP1, DDC | IDO1 113/4885AGXT 199/4885FFAR1 4593/4885 |
| US-20090306408-A1 | 2-Amino-Bicyclo (3.1.0) Hexane-2,6-Dicarboxylic Ester Derivative | GRIK4, GRIN2D, GRIN2C | IDO1 2753/4885AGXT 1813/4885FFAR1 39/4885 |
| US-20070021394-A1 | 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative | GRIN2C, GRIK4, GRIN2B | IDO1 3182/4885AGXT 1984/4885FFAR1 39/4885 |
| US-20180020662-A1 | Substituted 1-cycloalkyl-2-oxotetrahydroquinolin-6-ylsulfonamides or salts thereof and use thereof to increase stress tolerance in plants | CBR3, CBR1, CBS | IDO1 1077/4885AGXT 131/4885FFAR1 3429/4885 |
| US-20180199575-A1 | SUBSTITUTED OXOTETRAHYDROQUINOLINYLPHOSPHINIC ACID AND PHOSPHINIC ACID AMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS | PPA1, PHOSPHO1, PIP4K2C | IDO1 1337/4885AGXT 86/4885FFAR1 2704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.